智通财经APP获悉，阿里健康(00241)涨超4%，截至发稿，涨3.78%，报6.86港元，成交额5.32亿港元。
消息面上，1月19日，据证券日报报道，阿里健康重磅AI产品“氢离子”已完成内测并开放下载。据了解，该产品已进入实际应用阶段，主要面向临床、科研领域的医生群体。“氢离子”主打“低幻觉、高循证”核心能力，所有回答均有权威出处，支持一键溯源、直达信源，致力于打造医疗领域幻觉率最低的AI助手。
多位参与内测的医生反馈，“氢离子”在循证问答、证据整合与分析总结等任务中表现出高度准确度，尤其在临床、科研语境下的智能检索和中英文献研读方面，更贴合国内医生习惯。其产品逻辑与海外大热的OpenEvidence相似，但在本地化体验上更具优势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.